Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation

Blood

Volumn 95, Issue 11, 2000, Pages 3605-3612

  Adkins, Douglas R ^a   Goodnough, Lawrence T ^b   Shenoy, Shalini ^b   Brown, Randy ^b   Moellering, Jennifer ^b   Khoury, Hanna ^b   Vij, Ravi ^b   DiPersio, John ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; GRANULOCYTE TRANSFUSION; HUMAN; LEUKOCYTE; LYMPHOCYTOTOXICITY; NEUTROPHIL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION;

EID: 0034210230     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3605     Document Type: Article

References (29)

1. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood. 1992; 52:323-331.
2. Westrick MA, Debelak-Fehir KM, Epstein RB. The effect of prior whole blood transfusion on subsequent granulocyte support in leukopenic dogs. Transfusion. 1977;17:611-614.
3. Chow HS, Sarpel SC, Epstein RB. Pathophysiology of Candida albicans meningitis in normal, neutropenic, and granulocyte transfused dogs. Blood. 1980;55:546-551.
4. Appelbaum FR, Trapani RJ, Graw RG Jr. Consequences of prior alloimmunization during granulocyte transfusion. Transfusion. 1977;17:460-464.
5. Vamvakas EC, Pineda AA. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis. 1997;12:74-81.
6. McCullough J, Weiblen BJ, Clay ME, Forstrom L. Effect of leukocyte antibodies on the fate in vivo of indium-111-labeled granulocytes. Blood. 1981; 58:164-170.
7. Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood. 1983;62:354-360.
8. Goldstein IM, Eyre HJ, Terasaki PI, Henderson ES, Graw RG Jr. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion. 1971;11:19-24.
9. Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH. Alloimmunization following prophylactic granulocyte transfusion. Blood. 1979;54: 766-774.
10. Stroncek DF, Leonard K, Eiber G, et al. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009-1015.
11. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81:1883-1888.
12. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
13. Adkins D, Spitzer G, Johnston M, et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion. 1997;37:737-748.
14. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood. 1993;81:2866-2871.
15. Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1997;19:809-812.
16. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A. -B, -C, and -D antigens: the Phillip Levine Award Lecture. Am J Clin Pathol. 1978;69:103-120.
17. Mittal KK, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation: refinement of microdroplet lymphocyte cytotoxocity test. Transplantation. 1968;6:913-927.
18. Amos DB. Cytotoxicity testing. In: NAID Manual of Tissue Typing Techniques. Washington, DC: US Government Printing Office; 1976:25. DHEW publication NIH 76-545.
19. Fotino M. Histocompatibility Testing. Baltimore: Williams & Wilkins; 1970:595.
20. Adkins D, Ali S, Despotis G, Dynis M, Goodnough LT. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor. Transfusion. 1998;38: 557-564.
21. American Association of Blood Banks. Standards for blood banks and transfusion services. 17th ed. Bethesda, MD: American Association of Blood Banks; 1996.
22. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981;304:1185-1189.
23. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337:1861-1869.
24. Adkins DR. Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor [letter]. J Clin Oncol. 1998;16:812-813.
25. Strauss RG. Therapeutic granulocyte transfusions in 1993 [editorial]. Blood. 1993;81:1675-1678.
26. Graw RG, Eyre HJ, Goldstein IM, Terasaki PI. Histocompatibility testing for leucocyte transfusion. Lancet. 1970;1:77-78.
27. Chow HS, Alexander DL, Epstein RB. Detection and significance of granulocyte alloimmunization in leukocyte transfusion therapy on neutropenic dogs. Transfusion. 1983;23:15-19.
28. Stroncek DF. Granulocyte immunology: is there a need to know? Transfusion. 1997;37:886-888.
29. Schiffer CA. Prevention of alloimmunization against platelets. Blood. 1991;77:1-4.